Skip to main content
Top
Published in: Endocrine 1/2024

Open Access 25-09-2023 | Pituitary Adenoma | Original Article

Automated volumetric assessment of pituitary adenoma

Authors: Raffaele Da Mutten, Olivier Zanier, Olga Ciobanu-Caraus, Stefanos Voglis, Michael Hugelshofer, Athina Pangalu, Luca Regli, Carlo Serra, Victor E. Staartjes

Published in: Endocrine | Issue 1/2024

Login to get access

Abstract

Purpose

Assessment of pituitary adenoma (PA) volume and extent of resection (EOR) through manual segmentation is time-consuming and likely suffers from poor interrater agreement, especially postoperatively. Automated tumor segmentation and volumetry by use of deep learning techniques may provide more objective and quick volumetry.

Methods

We developed an automated volumetry pipeline for pituitary adenoma. Preoperative and three-month postoperative T1-weighted, contrast-enhanced magnetic resonance imaging (MRI) with manual segmentations were used for model training. After adequate preprocessing, an ensemble of convolutional neural networks (CNNs) was trained and validated for preoperative and postoperative automated segmentation of tumor tissue. Generalization was evaluated on a separate holdout set.

Results

In total, 193 image sets were used for training and 20 were held out for validation. At validation using the holdout set, our models (preoperative / postoperative) demonstrated a median Dice score of 0.71 (0.27) / 0 (0), a mean Jaccard score of 0.53 ± 0.21/0.030 ± 0.085 and a mean 95th percentile Hausdorff distance of 3.89 ± 1.96./12.199 ± 6.684. Pearson’s correlation coefficient for volume correlation was 0.85 / 0.22 and −0.14 for extent of resection. Gross total resection was detected with a sensitivity of 66.67% and specificity of 36.36%.

Conclusions

Our volumetry pipeline demonstrated its ability to accurately segment pituitary adenomas. This is highly valuable for lesion detection and evaluation of progression of pituitary incidentalomas. Postoperatively, however, objective and precise detection of residual tumor remains less successful. Larger datasets, more diverse data, and more elaborate modeling could potentially improve performance.
Literature
15.
go back to reference Ronneberger O., Fischer P., Brox T. (2015) U-Net: Convolutional Networks for Biomedical Image Segmentation. arXiv:150504597 [cs] Ronneberger O., Fischer P., Brox T. (2015) U-Net: Convolutional Networks for Biomedical Image Segmentation. arXiv:150504597 [cs]
17.
go back to reference Zettler N., Mastmeyer A. (2021) Comparison of 2D vs. 3D U-Net Organ Segmentation in abdominal 3D CT images Zettler N., Mastmeyer A. (2021) Comparison of 2D vs. 3D U-Net Organ Segmentation in abdominal 3D CT images
18.
go back to reference Van Rossum G., Drake Jr F.L. (1995) Python reference manual. Centrum voor Wiskunde en Informatica Amsterdam Van Rossum G., Drake Jr F.L. (1995) Python reference manual. Centrum voor Wiskunde en Informatica Amsterdam
23.
go back to reference Brett, M., Markiewicz Christopher J., Hanke, M., et al (2020) nipy/nibabel: 3.2.1 Brett, M., Markiewicz Christopher J., Hanke, M., et al (2020) nipy/nibabel: 3.2.1
29.
go back to reference Thapar K., Kovacs K., Scheithauer B., Lloyd R.V. (2001) Diagnosis and management of pituitary tumors. Humana Press Thapar K., Kovacs K., Scheithauer B., Lloyd R.V. (2001) Diagnosis and management of pituitary tumors. Humana Press
Metadata
Title
Automated volumetric assessment of pituitary adenoma
Authors
Raffaele Da Mutten
Olivier Zanier
Olga Ciobanu-Caraus
Stefanos Voglis
Michael Hugelshofer
Athina Pangalu
Luca Regli
Carlo Serra
Victor E. Staartjes
Publication date
25-09-2023
Publisher
Springer US
Published in
Endocrine / Issue 1/2024
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03529-x

Other articles of this Issue 1/2024

Endocrine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.